Valvular heart disease is common and its prevalence is rapidly increasing worldwide.
Effective medical therapies are insufficient and treatment was historically limited to the …

Transcatheter aortic valve implantation (TAVI) is currently performed through an alternative
access in 15% of patients. The transapical access is progressively being abandoned as a …

Background The recent approval of transcatheter aortic valve replacement (TAVR) in
patients with low operative risk has paved the way for the introduction of novel and …

Transcatheter heart valve interventions have transformed the outcomes of patients with
valvular heart disease (VHD) who are unfavourable candidates for surgery. Technological …

目的: 总结经导管主动脉瓣置换术(TAVR) 治疗重度主动脉瓣狭窄(AS) 的初步临床经验. 方法:
纳入2018 年10 月-2019 年10 月于我院接受TAVR 治疗的重度AS 患者21 例, 分析其临床资料 …

Transcatheter aortic valve implantation (TAVI) is the treatment of choice in patients with
symptomatic severe aortic stenosis who are either inoperable or at high risk for conventional …

Objectives: This study sought to examine whether the prognosis of patients with severe
aortic stenosis (AS) having high versus low transvalvular mean pressure gradients (MPGs) …

Aims: The aim of this study was to investigate whether minimising trauma to the aortic
annulus and left ventricular outflow tract reduces the occurrence of new conduction …

Abstract The True Infection Rate (TIR) in the whole population of each country and the
Infection Fatality Rate (IFR) for coronavirus disease 2019 (COVID-19) are unknown although …

Background Predictors for the need of permanent pacemaker implantation (PPMI) in the
context of transcatheter aortic valve implantation (TAVI) are not well defined yet. We …